Comparison of Dydrogesterone and Micronized Progesterone Treatments in the Treatment of Threatened Miscarriage.

Miscarriage Threatening Clinical Trial

Official title:

Comparison of Dydrogesterone and Micronized Progesterone Treatments in the Treatment of Threatened Miscarriage.

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT05542797
• Other study ID #: 351508
• Status: Not yet recruiting
• Phase: Phase 4
• Start date: October 2022
• Est. completion date: November 2024

Study information

• Verified date: September 2022
• Source: Konya Meram State Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

In this study, we aimed to compare the effects of two drugs used for the threated miscarriage on the miscarriage rate.

Description:

About 140 pregnant women who applied to our clinic due to the threated miscarriage in the first trimester will be randomly given micronized progesterone to half and dydrogesterone to the other half. After the treatment, the miscarriage rates in the groups will be compared.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 140
• Est. completion date: November 2024
• Est. primary completion date: October 2023
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years to 30 Years

Eligibility

Inclusion Criteria:

• pregnant women with threated miscarriage in the first trimester.

Exclusion Criteria:

• - pregnant women with abortus incipiens.

Related Conditions & MeSH terms

• Abortion, Spontaneous
• Abortion, Threatened
• Miscarriage Threatening

Intervention

Drug:
• Duphastone
dydrogesterone hormone

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Konya Meram State Hospital

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Miscarriage rate	Effects of two drugs to be used on live birth rate in pregnant women with threated miscarriage	One year